Porcine reproductive and respiratory syndrome virus (PRRSV) activates NF-κB during infection. We examined the ability of all 22 PRRSV genes for NF-κB regulation and determined the nucleocapsid (N) protein as the NF-κB activator. Protein inhibitor of activated STAT1 (signal transducer and activator of transcription 1) (PIAS1) was identified as a cellular protein binding to N. PIAS1 is known to bind to p65 (RelA) in the nucleus and blocks its DNA binding, thus functions as a repressor of NF-κB. Binding of n to PIAS1 released p65 for NF-κB activation. The N-terminal half of PIAS1 was mapped as the N-binding domain, and this region overlapped its p65-binding domain. For N, the region between 37 and 72 aa was identified as the binding domain to PIAS1, and this domain alone was able to activate NF-κB. A nuclear localization signal (NLS) knock-out mutant N did not activate NF-κB, and this is mostly likely due to the lack of its interaction with PIAS1 in the nucleus, demonstrating the positive correlation between the binding of N to PIAS1 and the NF-κB activation. Our study reveals a role of N in the nucleus for NF-κB activation and proinflammatory cytokine production during infection.
Results

nf-κB activation in PRRSV-infected cells.
To examine the regulation of NF-kB during infection, we infected ZMAC cells with PRRSV at 5 multiplicity of infection (moi) for 10 h. ZMAC is an established cell line of porcine alveolar macrophages, which are natural target cells for PRRSV, derived from lungs of porcine fetus 52 . The cells were stained with p65-specific polyclonal antibody (PAb) and PRRSV N-specific monoclonal antibody (MAb) MR40. As anticipated, p65 was distributed in the cytoplasm of ZAMC cells when not stimulated ( Fig. 1a) . When stimulated by adding lipopolysaccharide (LPS; 100 ng/ml) however, p65 predominantly accumulated in the nucleus (Fig. 1a ), indicating the activation of NF-κB in the macrophages. In PRRSV-infected cells, almost all of PRRSV-N positive ZMAC cells exhibited p65 accumulation in the nucleus even without LPS treatment (Fig. 1a) , demonstrating the activation of NF-κB by PRRSV.
Activation of NF-κB triggers expression of proinflammatory cytokines 23 . Thus, we examined the expression of IL-1β, IL-6, IL-8, and TNF-α in primary porcine alveolar macrophages (PAMs) during infection. Cells were infected with PRRSV at 1 moi for up to 48 h, and quantitative RT-PCR was conducted to measure respective transcripts. The kinetics of PRRSV replication was determined using the levels of N gene expression in virus-infected cells (Fig. 1b) . The N gene expression reached the peak at 12 h pi followed by gradual decrease until 48 h pi. The mRNA for IL-1β significantly (P = 0.00043) increased as early as 6 h postinfection (pi). Thereafter, IL-1β expression remained consistent until 24 h pi and reached its peak at 48 h pi. The elevated expression of IL-1β confirmed the activation of NF-κB in PAMs by PRRSV. The kinetics of IL-1β expression suggests the NF-κB activation was gradual and accumulating. Similar patterns of induction were observed for IL-6, IL-8, and TNF-α ( Fig. 1c ). Together, these data demonstrate the activation of NF-κB by PRRSV.
Identification of NF-κB activating proteins of PRRSV. The roles that PRRSV plays for modulation of NF-κB signaling are complicated. PRRSV activates NF-κB and stimulates proinflammatory cytokine production in virus-infected macrophages and pigs [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] 40 . (Fig. 1) . In other studies however, nonstructural protein (nsp) 1α, nsp1β, nsp4, and nsp11 suppress NF-κB signaling [53] [54] [55] [56] [57] [58] , whereas nsp2 activates 59 or inhibits 60 NF-κB depending on the strains of PRRSV. To identify viral proteins regulating NF-κB signaling, all 22 coding sequences of PRRSV except nsp2TF and nsp2N were individually cloned with a FLAG tag and expressed in HeLa cells as a fusion Figure 1 . Activation of NF-κB by PRRSV in ZMAC cells and primary porcine alveolar macrophages (PAMs). (a) ZMAC cells were infected with the PA8 strain of PRRSV at 5 moi for 10 h. Cells were stained with α-PRRSV-N MAb (MR40) (mouse) (green) and α-p65 PAb (rabbit) (red). The nuclei were stained with DAPI (blue). Images were taken by confocal microscopy (Nikon A1R). White arrows indicate the nucleus (Nu), and the orange arrow indicates the nucleolus (No) . Scales in micrometers (μm). (b,c) Primary PAMs were infected with PRRSV at 1 moi for indicated times, and total RNAs were isolated. RT-qPCR was performed to detect the levels of PRRSV-N genes (b) and transcripts for IL-1β, IL-6, IL-8, and TNF-α (c). The relative levels were calculated using the 2 −ΔΔCT method by normalizing the values to that of β-actin. The fold changes were compared to the levels at time zero. Error bars, mean ± standard deviation (s.d.). (n = 3). *P < 0.05, **P < 0.01, ***P < 0.001.
PRRSV nucleocapsid (N) protein-mediated NF-κB activation.
Since N was demonstrated as the NF-κB activator in HeLa cells ( Fig. 2) , this activity was further studied in other cell types. MARC-145 cells are permissive for PRRSV 61 and they were transfected with the NF-κB luciferase reporter and pRL-TK Renilla control plasmids along with an empty vector (pXJ41), nsp1α gene, or N gene for 42 h. Cells were then treated with TNF-α for 6 h, and the reporter expression was examined ( Fig. 3a ). Compared to mock-treated pXJ41 group, TNF-α treatment stimulated the luciferase activity by 4-fold in MARC-145 cells, indicating the normal activation of NF-κB signaling in the assay system. PRRSV nsp1α was known to suppress NF-κB signaling 55, 56 and thus, no activation of NF-κB was observed by nsp1α as expected ( Fig. 3a ). In contrast, N activated NF-κB signaling significantly (P = 0.0000821) although it was not as much as TNF-α stimulation ( Fig. 3a) , indicating the N-mediated NF-κB activation was not due to different cell types. The N-mediated NF-κB activation was determined using different amounts of N, and the signaling activation was positively correlated with the increasing amounts of N ( Fig. 3b ), indicating the dose-dependent activation of NF-κB by N.
We next examined the expression of proinflammatory cytokines mediated by N. MARC-145 cells were transfected with N gene for 42 h and treated with TNF-α for 6 h. Specific transcripts were then determined by RT-qPCR for IL-1β, IL-6, IL-8, and TNF-α (Fig. 3c ). The cytokine expressions were upregulated by N even without TNF-α stimulation, while pXJ41 or nsp1α as a negative control did not upregulate these cytokines. When stimulated with TNF-α, nsp1α suppressed these genes whereas pXJ41 and N elevated the expression of these cytokines. Together, these data showed that the N protein activates NF-κB signaling to promote the production of proinflammatory cytokines. NF-κB activation is mediated through the phosphorylation of p65 at position Ser536 followed by the translocation of phosphorylated p65 to the nucleus 22 . Thus, it was of interest to examine the subcellular distribution of p65 in cells expressing N using anti-p65 PAb and anti-FLAG MAb. Without stimulation, p65 was distributed in the cytoplasm of cells, but upon stimulation with TNF-α, it was translocated to the nucleus ( Fig. 3d , panels in second row). In nsp1α-expressing cells, p65 was distributed in the cytoplasm despite the stimulation ( Fig. 3d , panels in third row), indicating the suppression of p65 activation by nsp1α 55, 56 . In N-expressing cells however, p65 accumulated predominately in the nucleus ( Fig. 3d , panels in fourth row), indicating the p65 activation by N. The phosphorylation of p65 is an additional feature of activated NF-κB, and thus was also examined in N protein-expressing cells using a phosphorylated p65 (p-p65 S536 )-specific antibody (Fig. 3e ). The basal level of phosphorylated p65 (p-p65 S536 ) in HeLa cells increased rapidly when treated with TNF-α. In cells expressing N protein however, p-p65 S536 increased by two-fold even without TNF-α stimulation comparing to that of the basal level. The treatment of TNF-α for 5 min or 20 min enhanced p-p65 S536 in N-expressing cells, showing that the synergistic phosphorylation of p65 by TNF-α and N. Since N induced p65 phosphorylation, its nuclear translocation was examined by Western blot using p-p65 S536 antibody of the nuclear and cytoplasmic fractions from the cells expressing N (Fig. 3f ). The p-p65 S536 band was meager in the nuclear fraction of the control cells (lane 1) but became increased when stimulated with TNF-α (lane 2). In N-expressing cells, p-p65 S536 accumulated in the Binding of PRRSV nucleocapsid (N) protein to PIAS1. The basis for NF-κB activation by N remains unknown, and we attempted to identify cellular proteins interacting with N by yeast two-hybrid screening using N as the bait. The screening results showed that poly-A binding protein (PABP), human inhibitor of MyoD family a (I-mfa) domain containing protein (HIC), and protein inhibitor of activated STAT1 (PIAS1) were among the molecular partners of N. Of these proteins, N interactions with PABP and HIC have been reported 48, 50 , and PIAS1 was of our particular interest. PIAS1 has been reported as a negative regulator of NF-κB 28 , and so we hypothesized that N protein neutralized the PIAS1 activity by binding to it. To test this hypothesis, we first examined the colocalization of N and PIAS1 by IFA. HeLa cells were co-transfected with the FLAG-N and HA-PIAS1 plasmids, and IFA was conducted using anti-FLAG MAb and anti-HA MAb. The N protein was distributed in the cytoplasm and nucleus as anticipated ( Fig. 4a ). PIAS1 is reported to distribute in the cytoskeleton, cytoplasm, and majorly nucleus 28, 62 , and in the N and PIAS1 co-expressing cells, both proteins were found to colocalize in the cytoskeleton, cytoplasm, and nucleus ( Fig. 4a ), suggesting the binding of N to PIAS1. We confirmed their binding by performing a co-immunoprecipitation (co-IP) assay. Cells were co-transfected with the HA-PIAS1 and FLAG-N www.nature.com/scientificreports www.nature.com/scientificreports/ plasmids, and cell lysates were incubated with either anti-HA MAb or anti-PIAS1 MAb, followed by immunoblot using anti-FLAG Ab. Regardless of whether the PIAS1 expression was exogenous ( Fig. 4b ) or endogenous ( Fig. 4c ), N was pulled down by PIAS1 (second panel from top, lane 4), whereas FLAG-tagged nsp1α (F-nsp1α) or FLAG-tagged nsp1β (F-nsp1β) was not precipitated by PIAS1. To rule out a possibility of non-specific binding due to the overexpression of N or non-specific reactivity of the Abs, we performed additional co-IP for which cells were co-transfected with an equal amount of the HA-PIAS1 and FLAG-N plasmids, followed by pull-down assays using GFP MAb or HA MAb and immunoblotting with FLAG PAb (Fig. 4d ). FLAG-N was again coprecipitated by HA MAb (lane 2) while it was not coprecipitated by GFP MAb (lane 1), confirming the specific interaction of FLAG-N and PIAS1.
Competition binding of N to PIAS1 and release of p65. Since PIAS1 is known to bind to p65 of NF-κB and inhibits p65 binding to DNA 28 , we anticipated that the N-PIAS1 binding would disrupt the PIAS1-p65 interaction, which would result in the release of PIAS1 from p65 and the activation of NF-κB. To test this hypothesis, we conducted a competition co-IP assay. Cells were transfected with the HA-PIAS1 and p65 plasmids along with increasing amounts of N gene (Fig. 5a ). Lysates were incubated with anti-HA Mab, and the precipitates were subjected to Western blot using p65 MAb or FLAG PAb. p65 was pulled down by PIAS1 when N was absent (top panel, lane 2), confirming the PIAS1-p65 binding. When N was expressed however, the amount of p65 decreased (top panel), and the decrease of p65 was proportional to the increasing amounts of N (second panel). This finding indicates the competition between N and p65 for binding to PIAS1, and thus N-binding to PIAS1 may result in the release of p65 from PIAS1. Since the N-terminal 344 amino acids of PIAS1 contains the p65 binding region 28 , and because N competes with p65 for PIAS1 binding, we wanted to determine if the p65 binding region in PIAS1 was also responsible for the N-binding. Two truncations were made to represent 1-344 aa and 345-650 aa of PIAS1 and they were designated HA-PIAS1-NTD (N-terminal domain) and HA-PIAS1-CTD (C-terminal domain), respectively ( Fig. 5b) . We then performed co-IP experiments using cells over-expressing PIAS1 truncations and N. The N protein was precipitated by HA-PIAS1 (lane 3) and by HA-PIAS1-NTD (lane 4), whereas it was not precipitated by HA-PIAS1-CTD (lane 5). This result demonstrated the N-terminal 344 amino acids of PIAS1 was the N protein-binding region. This is the same region as the p65-binding region of PIAS1 and further supports that N and p65 compete from each other to bind to PIAS1.
If N bound to p65, it would also result in the disruption of p65-PIAS1 interaction, and thus, we examined if N was also able to bind to p65. We conducted co-IP using cells over-expressing p65 and N ( Fig. 5c ). Cell lysates co-expressing HA-PIAS1-NTD and N were incubated with p65 MAb, and the precipitates were subjected to Western blot with HA MAb or FLAG PAb. For this experiment, HA-PIAS1-NTD was preferred to full-length HA-PIAS1 since the expression level of HA-PIAS1-NTD was higher than that of HA-PIAS1 ( Fig. 5b , third panel), and so it would be harder for N to block the HA-PIAS1-NTD binding to p65. HA-PIAS1-NTD was pulled down by p65 ( Fig. 5c , top panel, lane 3), and the amount of HA-PIAS1-NTD was significantly reduced when N protein was present (lane 5). This further confirms that PIAS1-NTD binding to p65 is inhibited by N. Notably, N did not bind to p65 (Fig. 5c , second panel, lanes 4 and 5). These results demonstrated that the disruption of PIAS1-p65 interaction was not due to the binding of N to p65 but due to the binding of N to PIAS1-NTD.
The competition between PIAS1 and N for p65 binding was also examined in virus-infected cells. MARC-145 cells were infected with PRRSV at 5 moi for 48 h, and endogenous PIAS1 was precipitated using MAb from the cell lysates, and the precipitates were resolved and probed with p65 MAb and N PAb. It was evident that p65 was pulled down by PIAS1 MAb in mock-infected cells (Fig. 5d, top panel, lane 1) . In virus-infected cells however, p65 was not pulled down, and instead, N was pulled down by PIAS1 ( Fig. 5d, second panel, lane 2) , confirming the competition between N and PIAS1 for p65 binding in PRRSV-infected cells.
To determine the functional consequence of N-PIAS1 interaction, the NF-κB luciferase assay was performed in cells expressing PIAS1 or N ( Fig. 5e ). Cells transfected with an empty vector elicited 10-fold induction of NF-κB activity when stimulated with TNF-α. In contrast, the NF-κB activity decreased dramatically when PIAS1 was over-expressed, indicating the suppression of NF-κB by PIAS1. When the N expression was increased (Fig. 5e , bottom Western-blot bands), however, the NF-κB activity was reversed. Together, these data confirm that N binding to PIAS1 prevents PIAS1 binding to p65, thereby frees up p65 for activation.
Identification of PIAS1 binding region in N. PRRSV N contains multiple motifs; nuclear localization signal (NLS) 43, 44 , a noncovalent N-N interaction domain 63 , a nucleolar localization signal (NoLS) 43, 51 , phosphorylation sites, and a β-sheet domain 64 (Fig. 6a) . To determine the domain in N for NF-κB activation and to examine the correlation with PIAS1 binding, six deletion mutants of N, each fused with a FLAG tag, were constructed; C11 (representing 1-112 aa), C51 (1-72 aa), C86 (1-37 aa), N18 (18-123 aa), N41 (41-123 aa), and N73 (73-123 aa). Then, NF-κB-luciferase assays were performed for each construct by co-transfecting with the NF-κB-luciferase reporter (Fig. 6b ). The C11, C51, and N18 constructs showed the similar activity of NF-κB to that of full-length wild-type N (N-WT). N41 also activated NF-κB signaling but at a reduced rate than the above constructs. In contrast, C86 and N73 did not activate NF-κB, indicating the region between 37 and 72 aa of N was the essential domain for activation. Contained in this region are NLS and NoLS, suggesting that such localization signals might be crucial for NF-κB activation. To investigate the cellular distribution of N and its mutants, IFA was performed using anti-FLAG MAb. All mutants of N translocated to the nucleus including C86 and N73, although the NLS was absent in these mutants (Fig. 6c ). We reasoned that C86 (37 aa) and N73 (50 aa) were small in their size and thus passively diffused to the nucleus as previously reported 65 . Nevertheless, the nucleolar localization of N appeared to be NoLS-dependent since C11, C51, N18, and N41 localized in the nucleolus (Fig. 6c) , while C86 and N73 did not. This observation indicates the nuclear localization per se was not correlated with NF-κB activation in our transfection conditions. To determine the PIAS1-binding domain in N, we performed co-IP assays using individual deletion mutants. Cell lysates were precipitated using anti-HA MAb and probed with anti-FLAG PAb. N-WT, C11, N18, and N41 were pulled down by PIAS1 ( Fig. 6d, second panel, lanes 2, 3, 6, 7) , demonstrating that these constructs retained the PIAS1 binding ability. Since these constructs activated NF-κB ( Fig. 6b ), our results also indicate the positive correlation between PIAS1 binding of N and NF-κB activation. C51 was not initially detectable ( Fig. 6d, second panel, lane 4) , but with the increased amount of C51 plasmid for transfection and a longer exposure of the membrane, it was apparent that C51 was also pulled down by PIAS1 (Fig. 6d, third panel,  lane 4) , showing the binding of C51 to PIAS1. Taken altogether, these data indicate that the region between aa position 37 and 72 of N is the region for PIAS1 binding and also for NF-κB activation.
(e) N expression rescued NF-kB activity from PIAS1-mediated suppression. HeLa were transfected with NF-kB-luciferase reporter (0.5 μg) and pRL-TK plasmid (0.05 μg) along with PIAS1 plasmid (0.5 μg) alone or with PIAS1 (0.5 μg) and variable amounts of N plasmids together. Protein expressions were determined by Western blot using α-HA MAb, α-FLAG PAb, and α-β-actin MAb. β-actin served as a loading control. 24 h posttransfection, cells were stimulated with TNF-α (20 ng/ml) for 6 h. Error bars, mean ± s.d. (n = 3). Statistical significance was calculated by comparing the values to PIAS1 alone. P values were calculated using two-tailed Student's t-test. **P < 0.01, ***P < 0.001.
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www.nature.com/scientificreports www.nature.com/scientificreports/ nLS of n mediates nf-κB activation. The PIAS1 binding region (37 aa to 72 aa) of N includes NLS (41 aa to 47 aa) (Fig. 6d) , and the previous studies have shown that NLS is a determinant for the PRRSV pathogenesis in pigs 45, 46 . Thus, it was of an interest to examine the role of NLS in the N-mediated NF-κB activation. NLS functions by interacting with importin-α and importin-β via the conserved sequence of 41-PGKKNKK-47 in N 51 . We made an NLS knock-out N gene mutant to substitute two lysine (K) residues at 43 and 44 with two glycine (G) residues and designated this mutant as N-GG (Fig. 7a ). By IFA, N-WT was distributed in the cytoplasm, nucleus, and nucleolar in both HeLa and MARC-145 cells whereas N-GG did not enter the nucleus nor the nucleolus of cells (Fig. 7b ). When we examined the NF-κB activity using the luciferase assay, N-WT activated NF-κB in these cells; however, N-GG lost the activation drastically (Fig. 7c) . In HeLa cells, the NF-κB activity induced by N-GG was only slightly higher than that of pXJ41 empty vector, but was largely reduced compared to N-WT. In MARC-145 cells, N-GG did not induce the NF-κB activity and there was no difference between N-GG and pXJ41. These results indicate that NLS of N contributes to the NF-κB activity. We further examined the cellular distribution of p65 in N-GG expressing cells (Fig. 7d ). While N-WT caused the p65 translocation and accumulation in the nucleus, N-GG did not cause the p65 nuclear translocation and it was rather distributed in the cytoplasm, as with in the cells expressing nsp1α or empty vector, indicating no activation of NF-κB by N-GG. We also examined the proinflammatory cytokine expressions mediated by N-GG by RT-qPCR (Fig. 7e ). TNF-α or N-WT promoted the expression of IL-1β, IL-6, IL-8, and TNF-α, but N-GG did not induce the production of IL-1β, IL-6, and IL-8. Interestingly, TNF-α expression was slightly increased by 2-fold compared to pXJ41, but it was only about one-third of the level by N-WT. Together, these results show that NLS of N was important for N-mediated proinflammatory cytokine productions which is likely via NF-κB activation. N-GG did not bind to PIAS1. Since N-WT activated NF-κB while N-GG lost this activity, the interaction of N-GG and PIAS1 was examined. We co-transfected the HA-PIAS1 and N-GG plasmids in the equal molar ratio and conducted a pull-down assay using anti-HA MAb to determine whether N-GG was able to bind PIAS1. Surprisingly, a considerably reduced amount of N-GG was pulled down by HA-PIAS1 (Fig. 7f, top panel, lane 3) . N-GG binding to PIAS1 was not completely abolished when N-GG was over-expressed. Since PIAS1 resides in the nucleus and suppresses NF-κB 28 , we assumed that the lack of binding between N-GG and PIAS1 was likely due to their different cellular distributions. To examine this possibility, we performed PIAS1 staining. Regardless of cell types, PIAS1 was predominantly found in the nucleus (Fig. 7g ), and this observation was consistent with the previous finding from mouse embryo fibroblasts (MEFs) 28 .
N-GG did not localize in the nucleus as expected and this was likely because NLS was destroyed (Fig. 7b ). We also performed the nuclear complex co-IP. The nuclear lysates were prepared and subjected to co-IP using anti-PIAS1 MAb and to immunoblot using anti-FLAG PAb. Only N-WT was identified in the nuclear extract ( Fig. 7h, third panel, lane 2) , and N-GG was not detectable (third panel, lane 3). By co-IP, N-GG was not pulled down by PIAS1 (top panel, lane 3), indicating the absence of binding between N-GG and PIAS1 in the nucleus. The results showed that, although N-GG still retained a weak binding to PIAS1 when over-expressed, N-GG blocked the endogenous PIAS1-binding. Altogether, our data confirm the N-PIAS1 interaction leading to NF-κB activation.
SUMOylation of N. PIAS1 is a SUMO E3-ligase 38 . Since N was shown to bind to PIAS1, it was of interest to examine if N would be a SUMO substrate of PIAS1. During the co-IP experiment using PRRSV-infected cells, we observed a 25 K protein in addition to N of 15 K (Fig. 5d, bottom panel, lane 2) . The 25 K protein was routinely identified even under the denaturing conditions of SDS-PAGE, and its size was smaller than the dimer of N. The molecular weight of a SUMO molecule is 11 KDa, and thus we predicted that the 25 K protein was possibly a SUMOylated form of N 66, 67 . To examine this possibility, cells were infected with PRRSV at 5 moi for 48 h and a co-IP assay was conducted using PRRSV-N MAb and SUMO-1 or SUMO-2/3 antibody. The 25 K protein was identified in the virus-infected cells (Fig. 8a, lane 2) . This band was detectable by only SUMO-2/3 antibody in Western blot and co-IP (lane 6) but not by SUMO-1 antibody (lane 4). This finding indicates that N was conjugated by SUMO-2/3 modifier rather than by SUMO-1 modifier. To confirm this finding, IFA was performed using anti-HA Ab and anti-FLAG Ab in cells over-expressing HA-SUMO-1, HA-SUMO-2, or HA-SUMO-3 along with FLAG-N. It was evident that FLAG-N colocalized with HA-SUMO-2 or HA-SUMO-3 but did not colocalize with HA-SUMO-1 (Fig. 8b) . SUMO-2/3 conjugated N protein was also detectable in FLAG-N expressing cells (Fig. 8c,  upper panel, lanes 2 and 4) . This finding was consistent with the report that the N protein of Chinese Highly Pathogenic (HP)-PRRSV was SUMOylated by interacting with the Ubc9 68 . Our data demonstrate that PRRSV N was SUMOylated by SUMO-2/3 modifier.
Discussion
Proinflammatory cytokines play a wide range of cellular functions, and one major role is the contribution to host defense against infections. Production of proinflammatory cytokines is precisely balanced, and over-expression may cause tissue damages and immune-mediated diseases. PRRSV infects pulmonary alveolar macrophages (PAMs) in the lungs of pigs and causes inflammation and respiratory disease 5, 6 . Expressions of IL-1β and TNF-α are driven by NF-κB, and in turn, they are potent NF-κB activators 22 . This positive feedback maintains the homeostasis of a host so that the host can quickly build an antiviral status during infection. IL-6 is induced by IL-1β and TNF-α 69 and causes fever 70 . IL-8 is a neutrophil chemotactic factor and is also driven by NF-κB 71 . The production of such proinflammatory cytokines during PRRSV infection contributes to clinical and pathological outcome featured by fever, neutrophil infiltration to lungs, and tissue damages 10, 12 . The roles of PRRSV in NF-κB regulation seem complicates since the suppression and the activation have both been reported. The suppression is largely executed by nonstructural proteins, including nsp1α, nsp1β, nsp4, nsp5, and nsp11 [53] [54] [55] [56] [57] [58] , whereas the activation is attributed to structural proteins of E and N (Fig. 2) . The dual roles of PRRSV regulating NF-κB contribute to the overall pathogenesis of virus, but in cells and pigs, the virus as a whole activates NF-κB.
N is a potent viral activator for NF-κB (Fig. 2) . Previous studies have shown that PRRSV activates NF-κB, and the N protein is the viral component inducing NF-κB activation [17] [18] [19] [20] [21] 40, 41 . However, the mechanism of action remains unknown, and in the present study, we have determined the molecular basis for N-mediated NF-κB activation. Proinflammatory cytokines including IL-1β, IL-6, IL-8, and TNF-α are upregulated and peak at 48 hpi in primary PAMs during infection (Fig. 1c) . Our results show that N activates NF-κB luciferase signaling and (f) HeLa cells were transfected with the 2 μg of indicated genes for 30 h and subjected to co-IP. Cell lysates were immunoprecipitated with α-HA MAb followed by probing with α-FLAG PAb or α-HA MAb (top panel). (g) HeLa or MARC-145 cells were grown on cover slips and stained with α-PAIS1 (green). DAPI represents the nucleus. DIC, differential interference contrast. (h) HeLa cells were transfected with either F-N-WT (2 μg) or F-N-GG (2 μg), and the nuclear complex co-IPs were performed as described in Materials and Methods. www.nature.com/scientificreports www.nature.com/scientificreports/ induces the phosphorylation and nuclear translocation of p65 and confirms that N activates NF-κB (Figs 2 and 3) . By yeast two-hybrid and co-IP assays, we have determined PIAS1 as an N-binding protein. PIAS1 is a known NF-κB repressor 28 , and we show that N-PIAS1 binding releases p65 and activates NF-κB.
Based on the results, we propose a working model for PRRSV-mediated NF-κB activation. In resting cells, PIAS1 functions to repress p65 in the nucleus to keep it in check, and therefore only minimal levels of cytokines are produced for homeostasis. At an early phase of infection, a limited amount of N is produced and the majority www.nature.com/scientificreports www.nature.com/scientificreports/ of N is used for progeny virus production in the cytoplasm. PRRSV N is a nuclear-cytoplasmic protein 43, 44 , and thus some of N translocates to the nucleus, where it binds PIAS1 and releases p65. At this phase, most PIAS1 still remains as a complex with p65 and suppresses NF-κB, and the levels of proinflammatory cytokines are still low. As the infection proceeds, N concentration in the nucleus increases and the N binding to PIAS1 releases more p65. Released p65 then binds to the κB sites on DNA to initiate transcription of proinflammatory cytokine genes. Meanwhile, the replication process for viral genome will expose the viral RNA to the innate immune signaling cascade and activates relevant pathways which also triggers p65 phosphorylation in the cytoplasm. It has been shown that PRRSV infection induces the TLR4/MyD88 signaling pathway and NLRP3 inflammasome activation 13 . In addition, the expression of viral E protein contributes to the activation of inflammasome 21 . These factors together lead to the gradual expression of cytokines which are secreted from the cell and bind to their specific receptors to further stimulate the NF-κB signaling. As the N concentration becomes predominant in the nucleus, NF-κB activation is enhanced leading to inflammation.
Previously, we have constructed a series of N-NLS null-mutant PRRSVs and examined their pathogenesis in pigs 45, 46 . These studies have demonstrated a correlation between the N nuclear localization and clinical attenuation of PRRSV. Since PIAS1 is predominantly nuclear 28 and because N from NLS-null PRRSV remains in the cytoplasm, these studies support our model. Indeed, N-GG does not enter the nucleus and does not activate NF-κB ( Fig. 7) . Further studies show that losing NF-κB activity of N-GG is due to the lack of or reduced PIAS1 binding (Fig. 7) . Since N neutralizes the repressive function of PIAS1, NF-κB singling is sensitized, and NF-κB activation becomes faster and synergistic especially when coinfection with other pathogens occurs.
Porcine respiratory disease complex (PRDC) is a multifactorial disease of pigs, and PRRSV is frequently reported as the major pathogen in the diseased animals. In pigs coinfected with PRRSV and Mycoplasma hyopneumoniae or other bacterial pathogens, the production of proinflammatory cytokines is elevated, and the clinical disease become severe [72] [73] [74] . Elevated production of proinflammatory cytokines by PRRSV will benefit the virus. Although inflammation is mounted during the late stage of infection, recruitments of monocytes and macrophages to infection site provide fresh target cells for virus 10 . Viruses take advantage by modulating the NF-κB signaling to facilitate their own good or to cause disease 1-3 . The modulatory actions may vary for different viruses 1-3 . PIAS1 is an important NF-κB repressor that controls inflammation, and the PIAS family proteins are involved in regulating immune-related gene expressions 34, 35, 75 . Despite some viral proteins have been reported to interact with the PIAS family proteins and are SUMOylated 66, 67 , viral regulation of NF-κB through the PIAS family proteins is relatively new. VP35 of Ebola Zaire virus induces NF-κB activation in cells 76 and interacts with PIAS1 77 . NP of influenza A virus also activates NF-κB 78 and interacts with PIAS for SUMOylation 79 . The host Ubc9-mediated SUMOylation system was reported to exert adverse effects on PRRSV replication 68 . Since specific sites in N for SUMO conjugation are unknown, SUMOylation-negative mutant N proteins or mutant PRRSV cannot be generated for functional evaluation. Nevertheless, we report in this study that PRRSV N protein activates NF-κB through the mechanism of PIAS1 binding. The SUMOylation of N is an additional effect from this interaction, which further supports our finding of N-PIAS1 interaction. Our study presents a novel mechanism for PRRSV pathogenesis mediated by N and provides a new insight into viral regulation of inflammation by targeting the PIAS family proteins.
Materials and Methods
cells and viruses. ZMAC macrophages were described elsewhere 52 , and kindly provided by Dr. F. Zuckermann (University of Illinois). HeLa (NIH AIDS Research and Reference Reagent Program, Germantown, MD) and MARC-145 cells were cultivated in Dulbecco's modified Eagle's medium (DMEM; Mediatech Inc., Manassas, VA), supplemented with 10% heat-inactivated fetal bovine serum (FBS; Gibco, Grand Island, NY), in a humidified incubator with 5% CO 2 at 37 °C. Primary PAM cells were cultivated in RPMI-1640 medium (Mediatech Inc., Manassas, VA) supplemented with 10 mM glutamine and 10% heat-inactivated FBS. North American genotype PRRSV strain PA8 was propagated in MARC-145 cells and used for this study. For infection, cells were infected at a multiplicity of infection (moi) of 1 to 5 depending on experiments.
Antibodies and chemicals. The antibodies and chemicals used in the present study are listed as follow. Anti (α)-PRRSV-N MAb (MR40) (mouse) was obtained from E. Nelson (South Dakota State University, Brookings, SD). α-p65 PAb (rabbit) (H-286, sc-7151), α-p65 MAb (mouse) (F-6, sc-8008), α-PIAS1 MAb (mouse) (F-1, sc-365127), α-PARP PAb (rabbit) (H-250, sc-7150), α-HSP90 MAb (mouse) (4F10, sc-69703), α-SUMO1 MAb (mouse) (D-11, sc-5308), α-SUMO2/3 PAb (rabbit) (FL-103, sc-32873), and α-β-actin MAb (mouse) (C4, sc-47778) were purchased from Santa Cruz Biotechnologies Inc. (Santa Cruz, CA). α-FLAG MAb (rat) (M2) was purchased from Agilent Technologies Inc. (Cedar Creek, TX). α-FLAG PAb (rabbit) was purchased from Rockland Inc. (Gilbertsville, PA). α-GFP MAb (rabbit), α-HA MAb (mouse), α-PIAS1 PAb (rabbit), and Alexa-Flour 488-conjugated and Alexa-Flour 568-conjugated secondary antibodies were purchased from ThermoFisher (Rockford, IL). α-HA MAb (rabbit) (C29F4), α-phospho-NF-κB p65 (Ser 536) MAb (rabbit) (93H1), and human Tumor Necrosis Factor-α (TNF-α) (8902) were purchased from Cell Signaling (Danvers, MA). The peroxidase-conjugated Affinipure goat anti-mouse IgG and peroxidase-conjugated Affinipure goat anti-rabbit IgG were purchased from Jackson Immuno Research (West Grove, PA). Lipopolysaccharides (LPS) and DAPI (4′, 6′-diamidino-2-phenylindol) were purchased from Sigma (St. Louis, MO).
Genes and plasmids. The HA-PIAS1 and p65 genes were cloned into the pXJ41 expression vector. The nonstructural and structural genes were individually cloned in our laboratory from the FL12 infectious clone of PRRSV as the template 80 . The coding sequences were PCR-amplified to contain ATG translation initiation and TAG termination codons. A FLAG-tag was added at the N-terminus of each gene. For membrane protein genes such as nsp2, ORF2, ORF2a, ORF5, ORF5a, and ORF6, the FLAG-tag was added to the C-terminus. The
